ENTBF
Price
$0.09
Change
+$0.02 (+28.57%)
Updated
Jul 24 closing price
Capitalization
1.02M
HLOSF
Price
$3.44
Change
+$0.73 (+27.04%)
Updated
Jul 14 closing price
Capitalization
469.93M
Interact to see
Advertisement

ENTBF vs HLOSF

Header iconENTBF vs HLOSF Comparison
Open Charts ENTBF vs HLOSFBanner chart's image
ENTHEON BIOMEDICAL
Price$0.09
Change+$0.02 (+28.57%)
Volume$531
Capitalization1.02M
HEALIOS K K
Price$3.44
Change+$0.73 (+27.04%)
Volume$100
Capitalization469.93M
ENTBF vs HLOSF Comparison Chart in %
Loading...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTBF vs. HLOSF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTBF is a Hold and HLOSF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ENTBF: $0.09 vs. HLOSF: $3.43)
Brand notoriety: ENTBF and HLOSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTBF: 60% vs. HLOSF: 80%
Market capitalization -- ENTBF: $1.02M vs. HLOSF: $469.93M
ENTBF [@Biotechnology] is valued at $1.02M. HLOSF’s [@Biotechnology] market capitalization is $469.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTBF’s FA Score shows that 0 FA rating(s) are green whileHLOSF’s FA Score has 0 green FA rating(s).

  • ENTBF’s FA Score: 0 green, 5 red.
  • HLOSF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTBF is a better buy in the long-term than HLOSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTBF’s TA Score shows that 4 TA indicator(s) are bullish while HLOSF’s TA Score has 3 bullish TA indicator(s).

  • ENTBF’s TA Score: 4 bullish, 4 bearish.
  • HLOSF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both ENTBF and HLOSF are a good buy in the short-term.

Price Growth

ENTBF (@Biotechnology) experienced а +2.96% price change this week, while HLOSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($470M) has a higher market cap than ENTBF($1.02M). HLOSF YTD gains are higher at: 154.444 vs. ENTBF (-36.663). ENTBF has higher annual earnings (EBITDA): -403.94K vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 8.89B vs. ENTBF (525K). HLOSF has higher revenues than ENTBF: HLOSF (521M) vs ENTBF (0).
ENTBFHLOSFENTBF / HLOSF
Capitalization1.02M470M0%
EBITDA-403.94K-2.39B0%
Gain YTD-36.663154.444-24%
P/E RatioN/AN/A-
Revenue0521M-
Total Cash525K8.89B0%
Total DebtN/A6.1B-
TECHNICAL ANALYSIS
Technical Analysis
ENTBFHLOSF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
40%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
38%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
10%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRERX16.56N/A
N/A
Nuveen International Eq Retire
THPGX109.82N/A
N/A
Thompson LargeCap
NWKCX82.19N/A
N/A
Nationwide Geneva Small Cap Gr R6
WPVIX35.02N/A
N/A
Weitz Multi Cap Equity-Institutional Cl
HNRIX28.81N/A
N/A
Hennessy Energy Transition Instl

ENTBF and

Correlation & Price change

A.I.dvisor tells us that ENTBF and OVID have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTBF and OVID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTBF
1D Price
Change %
ENTBF100%
N/A
OVID - ENTBF
23%
Poorly correlated
-10.75%
IMRN - ENTBF
22%
Poorly correlated
-1.15%
ATNF - ENTBF
21%
Poorly correlated
+40.85%
CYBN - ENTBF
12%
Poorly correlated
-0.62%
HLOSF - ENTBF
7%
Poorly correlated
N/A
More

HLOSF and

Correlation & Price change

A.I.dvisor tells us that HLOSF and BRTX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLOSF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
BRTX - HLOSF
23%
Poorly correlated
-1.52%
LGVN - HLOSF
22%
Poorly correlated
-1.18%
ENTBF - HLOSF
7%
Poorly correlated
N/A
CPMV - HLOSF
5%
Poorly correlated
+25.37%
SLN - HLOSF
3%
Poorly correlated
+0.96%
More